Percutaneous transluminal septal myocardial ablation in a child with hypertrophic obstructive cardiomyopathy and noonan syndrome

Congenital Heart Disease

Volumn 3, Issue 5, 2008, Pages 347-351

  Singh, Harminder ^a   Kalra, Ravi ^a   Keshavamurthy, Ganapathi B ^a   Singh, Maninder ^b   Singh, Charanjit ^a  

^a MILITARY HOSPITAL   (India)

^b ARMED FORCES MEDICAL COLLEGE   (India)

Author keywords

Alcohol ablation; Cardiomyopathy; Congenital heart disease; Heart block; Myectomy; Noonan syndrome

Indexed keywords

HEPARIN; METOPROLOL;

ANGIOCARDIOGRAPHY; AORTA PRESSURE; ARTICLE; BALLOON CATHETER; CARDIOMEGALY; CASE REPORT; CATHETER ABLATION; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUS SEDATION; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; EXTRASYSTOLE; FOLLOW UP; HEART CATHETERIZATION; HEART LEFT VENTRICLE PRESSURE; HEART MURMUR; HEART RIGHT BUNDLE BRANCH BLOCK; HOLTER MONITORING; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; MITRAL VALVE REGURGITATION; NOONAN SYNDROME; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCHOOL CHILD; THORAX RADIOGRAPHY; TREATMENT DURATION; VASCULAR ACCESS;

CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; CHILD; ELECTROCARDIOGRAPHY; HEART SEPTUM; HUMANS; MALE; NOONAN SYNDROME;

EID: 52649104406     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2008.00179.x     Document Type: Article

References (20)

1. Nishimura RA, Holmes DR Jr. Clinical practice. Hypertrophic obstructive cardiomyopathy. N Engl J Med. 2004;350:1320-1327.
2. Maron BJ. Hypertrophic cardiomyopathy: A systematic review. JAMA. 2002;287:1308-1320.
3. Maron BJ, Dearani JA, Ommen SR, etal. The case for surgery in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004;44:2044-2053.
4. Maron BJ, McKenna WJ, Danielson GK, et al. American college of cardiology/European society of cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American college of cardiology foundation task force on clinical expert consensus documents and the European society of cardiology committee for practice guidelines. J Am Coll Cardiol. 2003;42:1687-1713.
5. Ommen SR, Maron BJ, Olivotto I, et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005;46:470-476.
6. Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol. 1998;31:252-258.
7. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995;346:211-214.
8. Kuhn H, Gietzen FH, Leuner C, etal. Transcoronary ablation of septal hypertrophy (TASH): A new treatment option for hypertrophic obstructive cardiomyopathy. Z Kardiol. 2000;89:IV41-54.
9. Hess OM, Sigwart U. New treatment strategies for hypertrophic obstructive cardiomyopathyT Alcohol ablation of the septum: the new gold standard? J Am Coll Cardiol. 2004;44:2054-2055.
10. Yetman AT, McCrindle BW. Management of pediatric hypertrophic cardiomyopathy. Curr Opin Cardiol. 2005;20:80-83.
11. Seggewiss H, Rigopoulos A. Management of hypertrophic cardiomyopathy in children. Paediatr Drugs. 2003;5:663-672.
12. Subash Chandra V, Jayranganth M, Shenoy AR. Non-surgical septal reduction for hypertrophic cardiomyopathy in childhood. Int J Cardiol. 2006;106:355-359.
13. Abbey S, Guérin P, Gournay V, Lefevre M, Crochet D. Septal alcoholisation of hypertrophic obstructive cardiomyopathy in childhood. Arch Mal Coeur Vaiss. 2005;98:574-578.
14. Gao YC, Li Y, Han L. Septal myocardial ablation for sick children with hypertrophic obstructive cardiomyopathy. Zhonghua Er Ke Za Zhi. 2007;45:231-232.
15. Emmel M, Sreeram N, deGiovanni JV, Brockmeier K. Radiofrequency catheter septal ablation for hypertrophic obstructive cardiomyopathy in childhood. Z Kardiol. 2005;94:699-703.
16. Nagueh SF, Ommen SR, Lakkis NM, etal. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2001;38:1701-1706.
17. Qin JX, Shiota T, Lever HM, et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous trans-luminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol. 2001;38:1994-2000.
18. Firoozi S, Elliott PM, Sharma S, et al. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic cardiomyopathy. Eur Heart J. 2002;23:1617-1624.
19. Chang SM, Nagueh SF, Spencer WH III, Lakkis NM. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy. J Am Coll Cardiol. 2003;42:296-300.
20. Holmes DR, Valeti US, Nishimura RA. Alcohol septal ablation for hypertrophic cardiomyopathy: Indications and technique. Catheter Cardiovasc Interv. 2005;66:375-389.